Treatment of TNNT1-Myopathy With L-Tyrosine.

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to investigate if treatment with L-Tyrosine improves selected outcome measures of TNNT1 myopathy.

• Phase: Phase 2

Details

• Lead Sponsor: Hadassah Medical Organization

Criteria

Inclusion Criteria:

• Male or female patients

• any age with TNNT1-related myopathy

Exclusion Criteria:

• Patients who are non-cooperative or parents/ legal guardians who are unwilling to sign consent form